Hess LM - Search Results

1

Intake of supplemental and total fiber and risk of colorectal adenoma recurrence in the wheat bran fiber trial.

Jacobs ET, Giuliano AR, Roe DJ, Guillén-Rodríguez JM, Hess LM, Alberts DS, Martínez ME. Jacobs ET, et al. Among authors: hess lm. Cancer Epidemiol Biomarkers Prev. 2002 Sep;11(9):906-14. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12223437 Clinical Trial.

2

Fecal bile acid concentrations in a subpopulation of the wheat bran fiber colon polyp trial.

Alberts DS, Einspahr JG, Earnest DL, Krutzsch MF, Lin P, Hess LM, Heddens DK, Roe DJ, Martínez ME, Salen G, Batta AK. Alberts DS, et al. Among authors: hess lm. Cancer Epidemiol Biomarkers Prev. 2003 Mar;12(3):197-200. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12646507 Clinical Trial.

3

Results of a phase I multiple-dose clinical study of ursodeoxycholic Acid.

Hess LM, Krutzsch MF, Guillen J, Chow HH, Einspahr J, Batta AK, Salen G, Reid ME, Earnest DL, Alberts DS. Hess LM, et al. Cancer Epidemiol Biomarkers Prev. 2004 May;13(5):861-7. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15159320 Clinical Trial.

4

What happened to the coxibs on the way to the cardiologist?

Alberts DS, Potter JD, Martinez ME, Hess LM, Stopeck A, Lance P. Alberts DS, et al. Among authors: hess lm. Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):555-6. doi: 10.1158/1055-9965.EPI-14-3-EDA. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15767326 No abstract available.

5

Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence.

Alberts DS, Martínez ME, Hess LM, Einspahr JG, Green SB, Bhattacharyya AK, Guillen J, Krutzsch M, Batta AK, Salen G, Fales L, Koonce K, Parish D, Clouser M, Roe D, Lance P; Phoenix and Tucson Gastroenterologist Networks. Alberts DS, et al. Among authors: hess lm. J Natl Cancer Inst. 2005 Jun 1;97(11):846-53. doi: 10.1093/jnci/dji144. J Natl Cancer Inst. 2005. PMID: 15928305 Clinical Trial.

6

Adherence assessment using medication weight in a phase IIb clinical trial of difluoromethylornithine for the chemoprevention of skin cancer.

Hess LM, Saboda K, Malone DC, Salasche S, Warneke J, Alberts DS. Hess LM, et al. Cancer Epidemiol Biomarkers Prev. 2005 Nov;14(11 Pt 1):2579-83. doi: 10.1158/1055-9965.EPI-05-0104. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 16284381 Clinical Trial.

7

Carcinogenesis and the hypothesis of phylogenetic reversion.

Bartels PH, Ranger-Moore J, Alberts D, Hess L, Scarpelli M, Montironi R. Bartels PH, et al. Anal Quant Cytol Histol. 2006 Oct;28(5):243-52. Anal Quant Cytol Histol. 2006. PMID: 17067006

8

Proceedings of a GOG workshop on intraperitoneal therapy for ovarian cancer.

Alberts DS, Markman M, Muggia F, Ozols RF, Eldermire E, Bookman MA, Chen T, Curtin J, Hess LM, Liebes L, Young RC, Trimble E. Alberts DS, et al. Among authors: hess lm. Gynecol Oncol. 2006 Dec;103(3):783-92. doi: 10.1016/j.ygyno.2006.09.012. Epub 2006 Oct 27. Gynecol Oncol. 2006. PMID: 17070570 Free PMC article.

9

The role of intraperitoneal therapy in advanced ovarian cancer.

Hess LM, Alberts DS. Hess LM, et al. Oncology (Williston Park). 2007 Feb;21(2):227-32; discussion 232, 235, 239-42. Oncology (Williston Park). 2007. PMID: 17396484 Free article. Review.

10

A meta-analysis of the efficacy of intraperitoneal cisplatin for the front-line treatment of ovarian cancer.

Hess LM, Benham-Hutchins M, Herzog TJ, Hsu CH, Malone DC, Skrepnek GH, Slack MK, Alberts DS. Hess LM, et al. Int J Gynecol Cancer. 2007 May-Jun;17(3):561-70. doi: 10.1111/j.1525-1438.2006.00846.x. Int J Gynecol Cancer. 2007. PMID: 17504373

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters